SEBI bans Omaxe for 3 months, fines ₹1.92 crore
Ask Iris
The regulatory action and why it matters
The Securities and Exchange Board of India (SEBI) has barred real estate firm Omaxe Ltd and five other related entities from accessing the securities market for periods ranging from three months to one year. The regulator also imposed a total monetary penalty of ₹1.92 crore. The action relates to alleged violations connected to minimum public shareholding (MPS) norms, with SEBI stating the entities created an artificial public shareholding structure to meet the requirement. The directions also restrict the entities from dealing in securities, including mutual fund units, during the restraint period. For listed companies, MPS compliance is a core listing condition, and enforcement actions can affect investor perception and governance scrutiny.
What SEBI alleged in the MPS matter
According to the order referenced in the report, SEBI found violations relating to Omaxe’s minimum public shareholding compliance. The regulator alleged that an artificial public shareholding structure was created to meet MPS norms. While the report does not provide the full mechanics of the alleged structure, it states the core charge as “creating an artificial public shareholding structure” to show compliance. SEBI’s directions in such cases typically focus on preventing further market participation while penalties are imposed for alleged misconduct. The restraint order is framed as a market-access prohibition and a bar on dealing in securities.
Who is barred and for how long
SEBI restrained Omaxe from accessing the securities market for three months. Three promoters, Rohtas Goel, Sunil Goel, and Jai Bhagwan Goel, were barred for one year. Two promoter entities, Dream Home Developers Pvt Ltd and Guild Builders Pvt Ltd, were also barred for one year. The report describes these directions as restraining the parties from accessing the securities market and prohibiting them from buying, selling, or otherwise dealing in securities directly or indirectly. The restrictions also cover being associated with the securities market “in any manner whatsoever” for the stated period.
What the prohibition covers
The directions extend beyond primary market access and include trading restrictions. SEBI’s restraint, as described, prohibits buying, selling, or otherwise dealing in securities, including mutual fund units. The prohibition is framed to include direct and indirect dealing, which can cover transactions routed through intermediaries or linked accounts. It also bars association with the securities market in any manner during the restraint period. Such wording is commonly used to prevent circumvention of restrictions via related parties or indirect arrangements.
Penalty: ₹1.92 crore total, with entity-wise fines
SEBI imposed a total fine of ₹1.92 crore on Omaxe and the five other parties named in the MPS matter. The report also provides the individual penalty amounts. Omaxe, Dream Home Developers, and Guild Builders were fined ₹27 lakh each, which is ₹0.27 crore per entity. Rohtas Goel, Sunil Goel, and Jai Bhagwan Goel were fined ₹37 lakh each, which is ₹0.37 crore per individual. These figures add up to the stated total penalty.
Key facts at a glance
Minimum public shareholding: the compliance issue behind the order
The immediate trigger for SEBI’s action, as stated, is non-compliance linked to MPS norms. MPS rules are intended to ensure a minimum level of public float in listed companies, supporting liquidity and market integrity. When the regulator alleges an “artificial” public shareholding structure, the concern is that reported public shareholding may not reflect genuine, independent public ownership. The report does not specify the exact percentage involved or the specific transactions, but it ties the directions and penalty directly to MPS-related violations.
Separate legal backdrop: SAT dismissal in an older SEBI case
Separately, the report also references proceedings before the Securities Appellate Tribunal (SAT) involving Omaxe and others. Omaxe said SAT dismissed its appeal against a SEBI order dated July 30, 2024, in an order pronounced on September 1, 2026. SAT, as cited, said round-tripping through subsidiaries and JBPL was used to “dress up” Omaxe’s financials and mislead investors. The text also notes that the September 1 order came against a July 2024 SEBI order that had restrained the appellants from accessing the securities market for two years and imposed monetary penalties, and that SAT dismissed the appeal. Omaxe said it was evaluating the order and its available legal remedies, and that the decision had no additional material impact on its financial, operational, or other activities.
What investors typically watch after such orders
Regulatory directions that restrict market participation can raise fresh questions around governance processes, promoter conduct, and compliance systems, even when the restraint period is time-bound. The immediate facts investors track include the exact duration of restrictions, the scope of the trading ban, and whether any further appeals or remedies are pursued. In this case, the reported SEBI directions are clear on duration, named entities, and the inclusion of mutual fund units within the dealing restrictions. The report also indicates that Omaxe has previously pursued appellate remedies in separate proceedings, and that it assesses legal options after adverse rulings.
Conclusion
SEBI’s order restraining Omaxe for three months and barring its promoters and promoter entities for one year, along with a ₹1.92 crore penalty, stems from alleged MPS-related violations and an alleged artificial public shareholding structure. The restrictions explicitly prohibit dealing in securities, including mutual fund units, during the restraint period. Separately, SAT has dismissed Omaxe’s appeal against a July 30, 2024 SEBI order in another matter, and the company has said it is evaluating legal remedies. Any next steps on the MPS order would likely be visible through disclosures and any appellate filings, if pursued.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
